AUCKLAND, New Zealand – 10 November 2022: In time for World Diabetes Day and as part of Diabetes Action Month, Dexcom Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, and its New Zealand subsidiary New Zealand Medical and Scientific Ltd (NZMS) Diabetes today announced the arrival of the …
11.11.2022
New Zealand first in the southern hemisphere to launch Dexcom G7 Continuous Glucose Monitoring System to improve diabetes management for Kiwis Latest technology becomes available as November marks World Diabetes Day and New Zealand Diabetes Action Month AUCKLAND, New Zealand – Thursday Oct. 27, 2022 – Dexcom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous …
Continue reading "NZMS Diabetes Launches the next-generation Dexcom CGM, Dexcom G7!"
26.10.2022
April 2022 – NZMS Diabetes is excited to announce the launch of Control-IQ™ technology for the t:slim X2™ insulin pump! The t:slim X2 insulin pump (compatible with Dexcom G6 continuous glucose monitoring) is capable of remote feature updates.* Recently, we welcomed the newest software to launch within New Zealand; Control-IQ. Control-IQ technology is an advanced …
Continue reading "Control-IQ Technology for the t:slim X2 Insulin Pump Launches in New Zealand"
04.04.2022
With our longstanding support for New Zealanders living with Type 1 diabetes, we are extremely pleased to share that PHARMAC is undertaking a review on CGM funding, following a recommendation by the PTAC Diabetes Subcommittee that the Dexcom G6 CGM system be listed on the Pharmaceutical Schedule with high priority. This review acknowledges the value …
Continue reading "PHARMAC undertakes a review on funding for Dexcom G6 CGM technology"
17.02.2022
Now you can get all the latest news and updates of our products, events and resources right into your inbox.